1985 - JUPITER ORGA LIMITED was incorporated as a Private Limited
Company on 21st
February, and converted into a Public Limited Company
vide Resolution passed on
10.3.92 with effect from 1.4.92 as evidenced by the
Registrar of Companies certificate
- The Company is in the Bulk Drugs and Basic Chemicals
industry and is currently
engaged in the manufacture of Trirnethoprim.
Sulfacetamide Sodium and Acetyl PAS.
- The Company was initially promoted to take up a small
scale project at Bidar, Karnataka,
for manufacturing bulk drugs and chemicals. The
Company has been making cash profits
since inception. The Company has also taken up trading
activities in Sodium PAS Ibuprofen.
Sulfamethoxazole, Paracetamol, Ranitidine and
- The Company will have two manufacturing units - one for
the manufacture of
Trimethoprim and Sulfacetamide Sodium at Bidar
(Karnataka), and the other for
the manufacture of Sodium Azide, 2-Methyl Resorcinol
and 2,6-Dimethoxy Phenol
and Trimethoprim at Sangareddy (Andhra Pradesh).
1995 - The Company is setting up a 100% Export Oriented Unit at
Sangareddy Mandal, Medak District, Andhra Pradesh for
which purpose funds have
been raised by way of public issue which opened on 30th
January, 1995 and was closed
on 2nd February.
- The Company has established a Research and Development
wing for the purpose of
developing the speciality chemicals.
1996 - Dr. G.K. Valecha retires at this Annual General Meeting and
being eligible for
re-appointment, offers himself to be re-elected as
Director. Smt. V. Indira retires in the
ensuing Annual General Meeting.
1998 - Dr. G.K. Valecha retires by rotation in the ensuing Annual
Meeting and is eligible for reappointment.
1999 - Mr. Gopal K.M. Tangirala retires by rotation in the ensuing
General Meeting and is eligible for reappointment. Dr.
expired during the year and the Board wishes to place on
appreciation of the services rendered by him during his
with the Company.
2000 - Jupiter Organics Ltd., the pharmaceutical and biotechnology
floated a wholly-owned subsidiary called Sven Genetech
Ltd. for setting up of
a separate and focused research and development facility
aimed at creating
new molecules based on peptide chemistry.
-Board declares dividend @ 16.5%.
- Jupitor Bioscience Inc is the 100% subsidiary of this company.
-It acquires manufacturing facility from Aurobindo Pharma.
-Hyderabad: Jupiter Biosciences Ltd (JBL), has forayed into an
alliance with GI Logics Inc to develop and market a diagnostic for H.
Pylori bacteria, which is responsible for peptic ulcers.
-E-mail ID for Investors